This adds to the Company’s impressive haul of 12 issued U.S. patents, and 70 issued patents globally for the extraction, purification, and delivery of cannabinoids. Next Leaf now claim to represent the 2nd largest patent portfolio of any cannabis company.
“We expect the results of the 2020 U.S. elections will have a transformational effect on the commercial value of our U.S. patent portfolio,” stated Paul Pedersen, CEO of Nextleaf Solutions (pictured above). “The world’s largest cannabis company launching the industry’s first patent infringement lawsuit against GW Pharma on December 22, 2020 demonstrates the value of patents and intellectual property in the cannabis industry.”
According to Next Leaf, this patented process to produce CBD-O-Acetate enables the standardization of a more potent analog of CBD through targeted drug delivery. Prodrugs utilize various physical and chemical modifications to improve features of active drugs. Maintaining the integrity of the molecule and its ability to deliver drugs to precisely targeted areas in the body may increase efficacy for desired outcomes.
The Company believes an orally consumable CBD metabolic prodrug produced under its patented process for acetylating cannabidiol will enhance the therapeutic potency of CBD.
OILS already owns U.S. patents for the acetylation of THC, and the acetylation of CBD. The Company’s patent portfolio and Health Canada licenses for cannabis processing and research presents an entry point for pharmaceutical firms looking to manufacture cannabinoid prodrugs in a federally legal jurisdiction.
The Company plans to commercialize this intellectual property through IP licensing, and the production of IP protected cannabinoid-based products as legally permitted by Health Canada.
Nextleaf also announce they will be working with Kronos Capital Partners Inc. to pursue and evaluate global strategic partners and investors. Kronos is a strategic advisor and an active investor in the global cannabis and life science sectors.
Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt bourse.